At least12 killed in building collapse near Mumbai

'US will remain dependent on India'

Clarke undergoes sixth cancer-related surgery

Can India-US tariff issue be resolved amicab;y?

Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.

Uploaded 1 month ago

Duration: 0h 5m 5s

Wockhardt exits US generics biz, to focus on innovation

Name: Wockhardt exits US generics biz, to focus on innovation
Uploaded: Sat, 12 Jul 2025 22:25:35 +0530
Channel: Rediff Video Desk
Description: Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations. The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.

Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations. The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.

Uploaded by: Rediff Video Desk on Sat, 12 Jul 2025 22:25:35 +0530

Views: 91

Tags: Wockhardt exits US generics biz, to focus on innovation

Share: